跳至主要内容
临床试验/NCT01577056
NCT01577056Unknown不适用

Effect of Fish Oil Supplementation on Postprandial Lipid Metabolism in Familial Hypercholesterolaemia

The University of Western Australia1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2012年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
30
试验地点
1
主要终点
Postprandial changes in triglyceride-rich lipoprotein concentrations

研究概览

简要总结

The purpose of this study is to determine whether fish oil supplementation is effective in the treatment of abnormal fat metabolism in subjects with elevated cholesterolaemia.

详细描述

The use of statin therapy in familial hypercholesterolaemia (FH) is known to reduce cardiovascular risk and is a first line recommendation, however, there is considerable residual risk predicted by the presence of fasting and post-prandial hypertriglyceridaemia.

This study will examine the effect of oral n-3 fatty acid ethyl esters supplementation (4g/day, Omacor) on postprandial hypertriglyceridaemia and post-prandial arterial function when administrated to FH patients at increased risk of cardiovascular disease due to their residual fasting hypertriglyceridaemia.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with FH (genetically defined LDL-receptor mutation or Dutch score >8) on statin treatment only
  • Hypertriglyceridaemia on a random blood sample (triglycerides >1.5mml/L)

排除标准

  • Subjects with diabetes mellitus
  • major systemic illness or use of steroids or other lipid-regulating drugs (such as niacin, fibrate and colesevelam)
  • patients on hypocaloric diets or LDL apheresis; anaemia, haemorrhage and pregnancy.

研究组 & 干预措施

Fish oil

Active Comparator

干预措施: Fish oil capsule (Dietary Supplement)

Placebo

Placebo Comparator

FH subjects with standard treatment (statin treatment)

干预措施: HMG Coenzyme reductase (Drug)

结局指标

主要结局

Postprandial changes in triglyceride-rich lipoprotein concentrations

时间窗: 12 weeks

Incremental area-under-the-curve (AUC) for triglycerides, apoB-48 and retinyl palmitate

次要结局

  • Triglyceride-rich lipoprotein kinetics(12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dick C Chan

Assistant Professor

The University of Western Australia

研究点 (1)

Loading locations...

相似试验